Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
Feltes, Timothy F. MD *; Cabalka, Allison K. MD; Meissner, H. Cody MD; Piazza, Franco M. MD, MPH; Carlin, David A. PhD; Top, Franklin H. Jr. MD; Connor, Edward M. MD; Sondheimer, Henry M. MD; for the Cardiac Synagis Study Group *
Journal of Pediatrics.
143(4):532-540, October 2003.
(Format: HTML, PDF)